Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 1.20p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.96
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 1,401.82m
  • Volume: 0
  • Market Cap: £16.82m
  • RiskGrade: 340
  • Beta: 0.73

Regulatory News

Notice of Extraordinary General Meeting 22-Nov-2024 12:49 RNS
IRB Approval for Phase I Clinical Trial 22-Nov-2024 07:00 RNS
Institutional Investment 11-Nov-2024 07:00 RNS
Schedule for Phase I Clinical Trial Opening 30-Oct-2024 07:00 RNS
Strategic Investment from Prevail Partners, LLC 02-Oct-2024 11:19 RNS
Half-year Report 27-Sep-2024 07:00 RNS
FLT3 Assay Ready for Phase I Trials at MD Anderson 09-Sep-2024 07:00 RNS
CDX Development Update 02-Sep-2024 07:00 RNS
Presentation at CBD S&T Conference 28-Aug-2024 07:00 RNS
Result of Annual General Meeting 27-Jun-2024 16:39 RNS
Operations Update 17-Jun-2024 07:00 RNS
Posting of Annual Report & Notice of AGM 03-Jun-2024 07:00 RNS
Final Results 25-Apr-2024 07:00 RNS
Total Voting Rights 28-Mar-2024 07:00 RNS
Placing to Raise US$4.2 million 29-Feb-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.20p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.96
52 Week Low 0.88
Volume 0
Shares Issued 1,401.82m
Market Cap £16.82m
Beta 0.73
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.11% below the market average51.11% below the market average51.11% below the market average51.11% below the market average51.11% below the market average
72% below the sector average72% below the sector average72% below the sector average72% below the sector average72% below the sector average
Price Trend
6.02% above the market average6.02% above the market average6.02% above the market average6.02% above the market average6.02% above the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page